Viewing Study NCT02188602


Ignite Creation Date: 2025-12-25 @ 3:40 AM
Ignite Modification Date: 2026-03-07 @ 4:05 PM
Study NCT ID: NCT02188602
Status: WITHDRAWN
Last Update Posted: 2022-08-22
First Post: 2013-07-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Cumulative Chloride Dose on Development of Acute Kidney Injury in Critically Ill Children
Sponsor: Stanford University
Organization:

Study Overview

Official Title: Retrospective Investigation of Chloride Dosing and Its Effect on Acute Kidney Injury
Status: WITHDRAWN
Status Verified Date: 2022-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Researcher left institution
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The investigators would like to investigate the effect of chloride dosing on the development of acute kidney injury in critically ill patients. The investigators hypothesis is that administering intravenous fluids with higher chloride content are more likely to lead to acute kidney injury.
Detailed Description: Retrospective chart review from 2008-2012 evaluating chloride dosing and serum chloride levels and their effects on acute kidney injury in the pediatric ICU. Patients will be included for the first seven days of their PICU stay.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: